Sage Therapeutics Inc put shares owned by Simplex Trading
Quarter-by-quarter ownership of Sage Therapeutics Inc put shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Sage Therapeutics Inc put
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics Inc put held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics Inc put by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $18k | 2.5k | 7.20 |
| 2024-06-30 | $19k | 1.8k | 10.56 |
| 2024-03-31 | $14k | 800 | 17.50 |
| 2023-12-31 | $283k | 13k | 21.60 |
| 2023-09-30 | $1.3M | 63k | 20.58 |
| 2023-06-30 | $286k | 6.1k | 46.89 |
| 2023-03-31 | $37k | 900 | 41.11 |
| 2022-12-31 | $22k | 600 | 36.67 |
| 2022-09-30 | $31k | 800 | 38.75 |
| 2022-06-30 | $2.4M | 73k | 32.29 |
| 2022-03-31 | $2.5M | 76k | 33.09 |
| 2021-12-31 | $3.9M | 69k | 57.36 |
| 2021-09-30 | $3.9M | 69k | 57.36 |
| 2021-06-30 | $4.0M | 70k | 56.80 |
| 2021-03-31 | $7.1k | 951 | 7.48 |
| 2020-12-31 | $2.4k | 274 | 8.65 |
| 2020-09-30 | $5.7k | 931 | 6.11 |
| 2020-06-30 | $1.0k | 244 | 4.16 |
| 2020-03-31 | $694 | 242 | 2.87 |
| 2019-12-31 | $1.2k | 164 | 7.21 |
| 2019-09-30 | $2.6k | 188 | 14.03 |
| 2019-06-30 | $4.7k | 254 | 18.31 |
| 2019-03-31 | $762 | 48 | 15.90 |
| 2018-12-31 | $1.1k | 111 | 9.58 |
| 2018-09-30 | $1.5k | 106 | 14.12 |
| 2018-06-30 | $2.1k | 136 | 15.65 |
| 2018-03-31 | $57k | 81 | 703.70 |
| 2017-12-31 | $71k | 643 | 110.42 |
| 2017-09-30 | $440k | 397 | 1108.31 |
| 2017-06-30 | $54k | 281 | 192.17 |
| 2017-03-31 | $122k | 295 | 413.56 |
| 2016-12-31 | $34k | 440 | 77.27 |
| 2016-09-30 | $79k | 760 | 103.95 |
| 2016-06-30 | $37k | 64 | 578.12 |
| 2016-03-31 | $1.0k | 4 | 250.00 |
| 2015-09-30 | $184k | 57 | 3228.07 |
| 2015-06-30 | $26k | 72 | 361.11 |
Top funds holding Sage Therapeutics Inc put
View all funds holding Sage Therapeutics Inc put